Skip to Content

93 64 (Rabeprazole Sodium Delayed-Release 20 mg)

Pill with imprint 93 64 is Yellow, Round and has been identified as Rabeprazole sodium delayed-release 20 mg. It is supplied by Teva Pharmaceuticals USA Inc..

Rabeprazole is used in the treatment of gerd; barrett's esophagus; duodenal ulcer; erosive esophagitis; duodenal ulcer prophylaxis (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Rabeprazole 20 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 93 64

Rabeprazole sodium delayed-release

93 64
20 mg
Prescription only
Drug Class:
Proton pump inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Teva Pharmaceuticals USA Inc.
National Drug Code (NDC):

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.